Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

MDS-ES Focused Workshop: Diagnostic and Progression Biomarkers in Parkinson’s Disease and Atypical Parkinsonism

Location:PaduaCME Credits:0Date:Feb 29, 2024 - Mar 02, 2024

Experienced / Intermediate

Program Description

This workshop will be focused on the extremely current topic of diagnostic and progression biomarkers in Parkinson’s disease and atypical parkinsonism. Given very recent developments in the use of seed amplification assays (SAA), neuroimaging and the development of novel biological therapies the topic is extremely important and will enable strong interactions between basic and clinical scientists, enabling ample opportunities for junior scientists to understand the challenges and implications of the use of biomarkers in the field.

Poster Session - Abstract Submission Available
The organizers invite applicants to submit an abstract for poster presentation during the poster session on March 1. Abstracts should be submitted on topics that are in line with the course program. Submission Deadline: December 8, 2023



  • Basic/Translational Neuroscience
  • Biomarkers & Diagnostic Tools
  • Epidemiology & Environment
  • Etiology & Pathophysiology
  • Genetics
  • Parkinson Disease/Hypokinetic Movement Disorders


Course Directors:

Angelo Antonini, MD, PhD - University of Padua, Padua, Italy

Tiago Outeiro, PhD - University Medical Center Goettingen, Goettingen, Germany


Erwan Bezard, PhD - Institute of Neurodegenerative Diseases, Bordeaux, France

Bas Bloem, MD, PhD - Radboud University Medical Center, Nijmegen, Netherlands

Matteo Bologna, MD, PhD - Sapienza University of Rome, Rome, Italy
Per Borghammer, MD, PhD, DMSc - Aarhus University Hospital, Aarhus, Denmark

Miryam Carecchio, MD, PhD - University of Padua, Padua, Italy

Maria Fiorella Contarino, MD, PhD - Leiden University Medical Center, Leiden, Netherlands

Günther Deuschl, MD, PhD - Christian-Albrechts University, Kiel, Germany

Omar El Agnaf, - Qatar Biomedical Research Institute, HBKU, Qatar Foundation, Doha, Qatar

Günter Höglinger, MD - Ludwig-Maximilians University Hospital, Munich, Germany

Christine Klein, MD, FEAN - University of Lubeck, Lubeck, Germany

Wassilios Meissner, MD, PhD - Institute of Neurodegenerative Diseases, University Bordeaux, Bordeaux, France

Ayami Okuzumi, MD, PhD - Juntendo University, Tokyo, Japan

Piero Parchi - University of Bologna, Bologna, Italy

Lucilla Parnetti, MD, PhD - University of Perugia, Perugia, Italy

Maria Teresa Pellecchia, MD, PhD - University of Salerno, Salerno, Italy

Werner Poewe, MD - Medical University Innsbruck, Innsbruck, Austria

Olivier Rascol, MD, PhD - University of Toulouse, Toulouse, France

Irena Rektorova, MD, PhD - St. Anne's University Hospital and CEITEC, Masaryk University, Brno, Czech Republic

Timothy Rittman, PhD, FRCP - University of Cambridge, Cambridge, United Kingdom

Marina Romero-Ramos, PhD - Aarhus University, Aarhus, Denmark

Jens Schwamborn - University of Luxembourg, Luxembourg

Nadia Stefanova, MD, PhD - Medical University of Innsbruck, Innsbruck, Austria

Per Svenningsson, MD, PhD - Karolinska Institutet, Stockholm, Sweden

Wilma D.J. Van de Berg, PhD - Amsterdam UMC, Vrije University, Amsterdam, Netherlands

Session Chairs: 

Luigi Bubacco, PhD - University of Padua, Padua, Italy

Paolo Calabresi, MD - Catholic University, Rome, Italy

Elisa Greggio, PhD - University of Padua, Padua, Italy

Fabrizio Stocchi, MD, PhD - University and IRCCS San Raffaele Roma, Rome, Italy

Alessandro Tessitore, MD, PhD - University Hospital "Luigi Vanvitelli", Naples, Italy

Michele Tinazzi, MD, PhD - University of Verona, Verona, Italy

Enza Maria Valente, MD, PhD - University of Pavia and IRCCS Mondino Foundation, Pavia, Italy

Course Purpose

The primary purpose of the course is to address current developments in the field of biomarkers for diagnosing and following disease progression, highlighting the potential impact for defining PD and for monitoring the impact of therapeutic interventions. It will also highlight how biomarkers could be introduced to better characterize patients undergoing invasive treatments and neuromodulation.

Registration Fees

Members: $300 USD

No Fee Members: $225 USD

Nonmembers: $400 USD

*Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of session.

Learning Objectives

Upon completion of this activity learners will be able to:

  1. Classify available biomarkers and understand their role and significance
  2. Compare the recent advances in the field of biomarker research in PD/atypical Parkinsonism
  3. Associate the use of particular assays with diagnosis and monitoring disease progression
  4. Demonstrate the impact of specific biomarkers on therapeutic interventions
  5. Document how biomarkers could change the management landscape in PD/atypical Parkinsonism

Intended Audience

This activity is intended for Movement Disorder Specialists, Clinicians, Faculty, Clinical Research Fellows, Movement Disorder Fellows, Basic Science Researchers, Translation Researches, Clinical Researches and Genetic Counseling Health Professionals. 

Contact Us

MDS Education

MDS Secretariat Liaison

Heather Vitale

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice